Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Brain functional plasticity at rest and during action in multiple sclerosis patients.
Elevated In Vivo Levels of a Single Transcription Factor Directly Convert Satellite Glia into Oligodendrocyte-like Cells.
Evaluating the Effects of White Matter Multiple Sclerosis Lesions on the Volume Estimation of 6 Brain Tissue Segmentation Methods.
Antiretrovirals inhibit arginase in human microglia.
Impaired growth of the cerebellum in pediatric-onset acquired CNS demyelinating disease.
Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice.
Morphostructural MRI abnormalities related to neuropsychiatric disorders associated to multiple sclerosis.
Neurodegeneration and inflammation in hippocampus in experimental autoimmune encephalomyelitis induced in rats by one - Time administration of encephalitogenic T cells.
New data show Novartis' Gilenya® reduced brain volume loss by one third and confirm brain volume loss link with disability in MS patients
The role of noninvasive and invasive diagnostic imaging techniques for detection of extra-cranial venous system anomalies and developmental variants.
A new CSF1R mutation presenting with an extensive white matter lesion mimicking primary progressive multiple sclerosis.
A Novel MPZ Gene Mutation in Exon 2 Causing Late-Onset Demyelinating Charcot-Marie-Tooth Disease.
MicroRNA-150: A potential regulator in pathogens infection and autoimmune diseases.
Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings.
A Low-Cost Cognitive Rehabilitation With a Commercial Video Game Improves Sustained Attention and Executive Functions in Multiple Sclerosis: A Pilot Study.
A role for Apolipoprotein A-I in the pathogenesis of multiple sclerosis.
Increased CXCL10 expression in MS MSCs and monocytes is unaffected by AHSCT.
Proof-of Concept that an Acute Trophic Factors Intervention After Spinal Cord Injury Provides an Adequate Niche for Neuroprotection, Recruitment of Nestin-Expressing Progenitors and Regeneration.
Improved neurite outgrowth on central nervous system myelin substrate by siRNA-mediated knockdown of Nogo receptor.
Changes in Synaptic Transmission and Long-term Potentiation Induction as a Possible Mechanism for Learning Disability in an Animal Model of Multiple Sclerosis.
The Symbol Digit Modalities Test is an effective cognitive screen in pediatric onset multiple sclerosis (MS).
Aging with multiple sclerosis: cognitive, emotional and neuropathological considerations.
More on JC viremia in natalizumab-treated patients with multiple sclerosis.
Epidemiological, clinical and immunological aspects of neuromyelitis optica (NMO).
Alterations of brain eicosanoid synthetic pathway in multiple sclerosis and in animal models of demyelination: Role of cyclooxygenase-2.
Pages
« first
‹ previous
…
655
656
657
658
659
660
661
662
663
…
next ›
last »